Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 May;19(5):754–760. doi: 10.1128/aac.19.5.754

Liquid chromatographic assay for metronidazole and tinidazole: pharmacokinetic and metabolic studies in human subjects.

I Nilsson-Ehle, B Ursing, P Nilsson-Ehle
PMCID: PMC181517  PMID: 7294765

Abstract

We developed methods for measuring metronidazole, its two major metabolites, and tinidazole in serum and urine. After treatment of each sample with an equal volume of 5% perchloric acid, the drugs were separated by reverse-phase high-pressure liquid chromatography (retention times, 6 to 18 min). Quantitation was based on spectrometry at 320 nm. These assays were sensitive, rapid, and specific, and recoveries from biological samples were quantitative. Metronidazole and tinidazole were given as rapid intravenous infusions to four healthy human volunteers. The biological half-lives of these two compounds were 5.4 and 11.1 h, respectively. The hydroxy metabolite of metronidazole appeared quickly in serum and was eliminated at a slow rate. The acetic acid metabolite of metronidazole was detected in serum at very low levels and only for a limited time. No metabolic products of tinidazole were found in serum samples. In urine, 43.7% of the administered dose of metronidazole was recovered over a period of 24 h (24.1% of the dose as the hydroxy metabolite, 12.0% as the acetic acid metabolite, and 7.6% as unchanged drug). Only 18.4% of the infused dose of tinidazole was eliminated in urine over a period of 72 h, and no metabolic products were detected.

Full text

PDF
754

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amon I., Amon K., Hüller H. Pharmacokinetics and therapeutic efficacy of metronidazole at different dosages. Int J Clin Pharmacol Biopharm. 1978 Aug;16(8):384–386. [PubMed] [Google Scholar]
  2. Arabi Y., Dimock F., Burdon D. W., Alexander-Williams J., Keighley M. R. Influence of neomycin and metronidazole on colonic microflora of volunteers. J Antimicrob Chemother. 1979 Sep;5(5):531–537. doi: 10.1093/jac/5.5.531. [DOI] [PubMed] [Google Scholar]
  3. DeSilva J. A., Munno N., Strojny N. Absorptiometric, polarographic, and gas chromatographic assays for the determination of N-1-substituted nitroimidazoles in blood and urine. J Pharm Sci. 1970 Feb;59(2):201–210. doi: 10.1002/jps.2600590213. [DOI] [PubMed] [Google Scholar]
  4. Dornbusch K., Nord C. E. In vitro effect of metronidazole and tinidazole on anaerobic bacteria. Med Microbiol Immunol. 1974;160(4):265–267. doi: 10.1007/BF02121441. [DOI] [PubMed] [Google Scholar]
  5. Dornbusch K., Nord C. E., Olsson B. Antibiotic susceptibility testing of anaerobic bacteria by the standardized disc diffusion method with special reference to bacteroides fragilis. Scand J Infect Dis. 1975;7(1):59–66. doi: 10.3109/inf.1975.7.issue-1.11. [DOI] [PubMed] [Google Scholar]
  6. Gulaid A., Houghton G. W., Lewellen O. R., Smith J., Thorne P. S. Determination of metronidazole and its two major metabolites in biological fluids by high pressure liquid chromatography. Br J Clin Pharmacol. 1978 Nov;6(5):430–432. doi: 10.1111/j.1365-2125.1978.tb04608.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Houghton G. W., Smith J., Thorne P. S., Templeton R. The pharmacokinetics of oral and intravenous metronidazole in man. J Antimicrob Chemother. 1979 Sep;5(5):621–623. doi: 10.1093/jac/5.5.621. [DOI] [PubMed] [Google Scholar]
  8. Houghton G. W., Thorne P. S., Smith J., Templeton R., Collier J. Comparison of the pharmacokinetics of metronidazole in healthy female volunteers following either a single oral or intravenous dose. Br J Clin Pharmacol. 1979 Oct;8(4):337–341. doi: 10.1111/j.1365-2125.1979.tb04715.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ingham H. R., Rich G. E., Selkon J. B., Hale J. H., Roxby C. M., Betty M. J., Johnson R. W., Uldall P. R. Treatment with metronidazole of three patients with serious infections due to Bacteroides fragilis. J Antimicrob Chemother. 1975 Jun;1(2):235–242. doi: 10.1093/jac/1.2.235. [DOI] [PubMed] [Google Scholar]
  10. Jokipii L., Jokipii A. M. Metronidazole bioassay with increased sensitivity. Med Microbiol Immunol. 1979 Mar 13;167(1):61–70. doi: 10.1007/BF02123297. [DOI] [PubMed] [Google Scholar]
  11. Lanbeck K., Lindström B. Determination of metronidazole and tinidazole in plasma and feces by high-performance liquid chromatography. J Chromatogr. 1979 Jan 1;162(1):117–121. doi: 10.1016/s0378-4347(00)82072-1. [DOI] [PubMed] [Google Scholar]
  12. Levison M. E. Microbiological agar diffusion assay for metronidazole concentrations in serum. Antimicrob Agents Chemother. 1974 May;5(5):466–468. doi: 10.1128/aac.5.5.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Melander A., Kahlmeter G., Kamme C., Ursing B. Bioavailability of metronidazole in fasting and non-fasting healthy subjects and in patients with Crohn's disease. Eur J Clin Pharmacol. 1977 Aug 17;12(1):69–72. doi: 10.1007/BF00561408. [DOI] [PubMed] [Google Scholar]
  14. Midha K. K., McGilveray I. J., Cooper J. K. Determination of therapeutic levels of metronidazole in plasma by gas-liquid chromatography. J Chromatogr. 1973 Dec 19;87(2):491–497. doi: 10.1016/s0021-9673(01)91751-0. [DOI] [PubMed] [Google Scholar]
  15. Nachbaur J., Joly H. Rapid assay of tinidazole in plasma by high-performance liquid chromatography. J Chromatogr. 1978 Mar 1;145(2):325–327. doi: 10.1016/s0378-4347(00)81357-2. [DOI] [PubMed] [Google Scholar]
  16. Ralph E. D., Clarke J. T., Libke R. D., Luthy R. P., Kirby W. M. Pharmacokinetics of metronidazole as determined by bioassay. Antimicrob Agents Chemother. 1974 Dec;6(6):691–696. doi: 10.1128/aac.6.6.691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ralph E. D., Kirby W. M. Bioassay of metronidazole with either anaerobic or aerobic incubation. J Infect Dis. 1975 Nov;132(5):587–591. doi: 10.1093/infdis/132.5.587. [DOI] [PubMed] [Google Scholar]
  18. Schwartz D. E., Jeunet F. Comparative pharmacokinetic studies of ornidazole and metronidazole in man. Chemotherapy. 1976;22(1):19–29. doi: 10.1159/000221906. [DOI] [PubMed] [Google Scholar]
  19. Stambaugh J. E., Feo L. G., Manthei R. W. The isolation and identification of the urinary oxidative metabolites of metronidazole in man. J Pharmacol Exp Ther. 1968 Jun;161(2):373–381. [PubMed] [Google Scholar]
  20. Tally F. P., Sutter V. L., Finegold S. M. Treatment of anaerobic infections with metronidazole. Antimicrob Agents Chemother. 1975 May;7(5):672–675. doi: 10.1128/aac.7.5.672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Welling P. G., Monro A. M. The pharmacokinetics of metronidazole and tinidazole in man. Arzneimittelforschung. 1972 Dec;22(12):2128–2132. [PubMed] [Google Scholar]
  22. Wood N. F. GLC analysis of metronidazole in human plasma. J Pharm Sci. 1975 Jun;64(6):1048–1049. doi: 10.1002/jps.2600640642. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES